You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Solifenacin Succinate

Showing 26 - 50 of 277
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Urinary Bladder, Overactive Trial in Worldwide (Solifenacin succinate suspension 2.5 mg, Solifenacin succinate suspension 5 mg,

Completed
  • Urinary Bladder, Overactive
  • Solifenacin succinate suspension 2.5 mg
  • +2 more
  • Ghent, Belgium
  • +7 more
Oct 26, 2018

Urinary Bladder, Neurogenic, Multiple Sclerosis Trial in Lausanne (VESIcare 10Mg Tablet, Botox 100 UNT Injection)

Recruiting
  • Urinary Bladder, Neurogenic
  • Multiple Sclerosis
  • VESIcare 10Mg Tablet
  • Botox 100 UNT Injection
  • Lausanne, Switzerland
    Centre Hospitalier Universitaire Vaudois
Feb 4, 2022

Neurogenic Detrusor Overactivity Trial in Worldwide (Solifenacin succinate)

Completed
Has Results
  • Neurogenic Detrusor Overactivity
  • Solifenacin succinate
  • Tarrytown, New York
  • +20 more
Apr 10, 2019

Neurogenic Detrusor Overactivity, Pediatric Trial in Worldwide (Solifenacin succinate)

Completed
Has Results
  • Neurogenic Detrusor Overactivity
  • Pediatric
  • Solifenacin succinate
  • Tarrytown, New York
  • +7 more
Oct 17, 2018

Sjogren's Syndrome, Overactive Bladder Syndrome Trial in Taichung (mirabegron, oxybutynin, tolterodine, solifenacin)

Recruiting
  • Sjogren's Syndrome
  • Overactive Bladder Syndrome
  • Taichung, Taiwan
    China Medical University Hospital
Aug 8, 2021

Urinary Incontinence, Urgency Urinary Trial in Boston (Oxybutynin, Solifenacin, Tolterodine, Sanctura or Toviaz)

Completed
Has Results
  • Urinary Incontinence
  • Urgency Urinary
  • Oxybutynin, Solifenacin, Tolterodine, Trospium, or Fesoterodine
  • Boston, Massachusetts
    Brigham & Women's Hospital
Oct 21, 2022

Overactive Bladder, Neurogenic Detrusor Overactivity Trial in Worldwide (Solifenacin succinate suspension 5 mg)

Completed
  • Overactive Bladder
  • Neurogenic Detrusor Overactivity
  • Solifenacin succinate suspension 5 mg
  • Gent, Belgium
  • +6 more
Oct 26, 2018

Urinary Bladder, Overactive Trial in Worldwide (Solifenacin succinate suspension)

Completed
Has Results
  • Urinary Bladder, Overactive
  • Solifenacin succinate suspension
  • Shreveport, Louisiana
  • +38 more
Oct 19, 2018

Urinary Bladder, Overactive Trial in Worldwide (Solifenacin Succinate Suspension, Placebo, Urotherapy)

Completed
Has Results
  • Urinary Bladder, Overactive
  • Solifenacin Succinate Suspension
  • +2 more
  • Shreveport, Louisiana
  • +45 more
Oct 1, 2018

Urinary Incontinence Trial in El Palmar (Solifenacin Succinate, Neuro-Muscular Stimulators (NMS))

Unknown status
  • Urinary Incontinence
  • Solifenacin Succinate
  • Neuro-Muscular Stimulators (NMS)
  • El Palmar, Murcia, Spain
    Hospital Clínico Universtario Virgen de la Arrixaca
Aug 1, 2018

Overactive Bladder Trial in Dhaka (Mirabegron 25mg, Solifenacin Succinate 5 MG)

Completed
  • Overactive Bladder
  • Mirabegron 25mg
  • Solifenacin Succinate 5 MG
  • Dhaka, Bangladesh
    Bangabandhu Sheikh Mujib Medical University
Jun 18, 2018

Obstructive Hypertrophic Cardiomyopathy (oHCM) Trial (Aficamten (CK-3773274) (5 mg, 10 mg, 15 mg and 20 mg), Placebo to match

Not yet recruiting
  • Obstructive Hypertrophic Cardiomyopathy (oHCM)
  • Aficamten (CK-3773274) (5 mg, 10 mg, 15 mg and 20 mg)
  • +3 more
  • (no location specified)
Mar 2, 2023

Gastric Cancer Trial in Seoul (Arm I : Experimental (Prucalopride succinate group), Arm II : Control (Mosapride citrate group))

Completed
  • Gastric Cancer
  • Arm I : Experimental (Prucalopride succinate group)
  • Arm II : Control (Mosapride citrate group)
  • Seoul, Korea, Republic of
    GangnamSeverance Hospital
Jul 21, 2023

Overactive Bladder Trial in France (Succinate of Solifenacin, Placebo of Succinate of Solifenacin)

Terminated
  • Overactive Bladder
  • Succinate of Solifenacin
  • Placebo of Succinate of Solifenacin
  • Brest, France
  • +4 more
Jan 18, 2018

End-Stage Kidney Disease, End-Stage Renal Disease Trial in Boston, Minneapolis, New York (Metoprolol Succinate, Carvedilol)

Not yet recruiting
  • End-Stage Kidney Disease
  • End-Stage Renal Disease
  • Boston, Massachusetts
  • +4 more
Jun 26, 2023

Urinary Incontinence Trial in Canada, United States (solifenacin succinate, Placebo)

Completed
Has Results
  • Urinary Incontinence
  • solifenacin succinate
  • Placebo
  • Homewood, Alabama
  • +59 more
Jul 31, 2018

Lower Urinary Tract Symptoms, Benign Prostatic Hyperplasia Trial in Seoul (Tamsulosin 0.2mg + Solifenacin 5mg, Tamsulosin 0.2mg

Completed
  • Lower Urinary Tract Symptoms
  • Benign Prostatic Hyperplasia
  • Tamsulosin 0.2mg + Solifenacin 5mg
  • Tamsulosin 0.2mg + Placebo(Solifenacin)
  • Seoul, Korea, Republic of
    Asan Medical Center
Aug 27, 2019

Assay to Measure Beta Blocker Adherence

Recruiting
  • Congestive Heart Failure
  • Medication Adherence
  • Quest beta blocker assay
  • Akron, Ohio
    Summa Health System
Mar 4, 2022

Lower Urinary Tract Symptoms Trial in Houston (Tamsulosin, Solifenacin)

Completed
Has Results
  • Lower Urinary Tract Symptoms
  • Houston, Texas
    The Methodist Hospital System
Mar 19, 2018

Overactive Bladder, Dementia, Lower Urinary Tract Symptoms Trial in Houston, Temple (Anticholinergic, Beta-3 Agonists,

Unknown status
  • Overactive Bladder
  • +3 more
  • Houston, Texas
  • +1 more
Apr 1, 2020

Overactive Bladder Trial in Seoul (Oxybutinin, Fesoterodine, Solifenacin, Propiverin, Trospium)

Completed
  • Overactive Bladder
  • Oxybutinin, Fesoterodine, Solifenacin, Propiverin, Trospium
  • Seoul, Korea, Republic of
    Samsung Medical Center
Nov 28, 2019

Nausea and Vomiting of Pregnancy Trial in United States (doxylamine succinate 10 mg/pyridoxine HCl 10 mg, Placebo)

Completed
Has Results
  • Nausea and Vomiting of Pregnancy
  • doxylamine succinate 10 mg/pyridoxine hydrochloride 10 mg
  • Placebo
  • Washington, District of Columbia
  • +6 more
Nov 22, 2021

Hypertension Trial in Aurora (drug, genetic, procedure)

Terminated
Has Results
  • Hypertension
  • metoprolol succinate
  • +2 more
  • Aurora, Colorado
    University of Colorado Denver; Emergency Department
Aug 18, 2021

Cardiac Disease, Bleeding Postoperative Trial in Aurora (Fresh Autologous whole Blood, Standard of Care Expectant management of

Recruiting
  • Cardiac Disease
  • Bleeding Postoperative
  • Fresh Autologous whole Blood
  • Standard of Care Expectant management of bleeding
  • Aurora, Colorado
    University of Colorado Hospital
Jan 28, 2022

Correction of Metabolic Disorders and Its Effect on Respiratory

Completed
  • COVID-19
  • Nizhny Novgorod, Russian Federation
    Nizhegorodskaya Regional Clinical Hospital named after N.A. Sema
Dec 23, 2021